Joseph Antonios

Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7

Secure, privacy-preserving and federated machine learning in medical imaging

The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications

Engineering precision nanoparticles for drug delivery

Precision histology: how deep learning is poised to revitalize histomorphology for personalized cancer care

Immuno-Oncology: Emerging Targets and Combination Therapies

Inflammation and tumor progression: signaling pathways and targeted intervention

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results

Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations

Artificial intelligence in radiology

Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy

CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas

TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination

PD-1 blockade enhances the vaccination-induced immune response in glioma

Immunosuppressive tumor-infiltrating myeloid cells mediate adaptive immune resistance via a PD-1/PD-L1 mechanism in glioblastoma

Detection of immune responses after immunotherapy in glioblastoma using PET and MRI